Nautilus Biotechnology, Inc (NAUT) insider trading
Every open-market stock purchase and sale by Nautilus Biotechnology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $11.8M over the last 12 months (1 sale).
- Last insider buy: Sujal M Patel (CEO), $65.2K, 7 months ago.
Last 12 months: insiders bought $71.2K (2 buys) and sold $11.8M (1 sale). Last close $2.39 on Jun 4, 2026.
Recent NAUT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | Melissa B Epperly (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Karen Akinsanya (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Farzad Nazem (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Matthew S McIlwain (Director) | Bought (not open market) | — |
| Jun 18, 2026 | Matthew L. Posard (Director) | Bought (not open market) | — |
| Jun 2, 2026 | AH Equity Partners Bio II L.L.C. (Insider) | Sold | $10.8M |
| Jun 2, 2026 | AH Equity Partners Bio II L.L.C. (Insider) | Sold | $902K |
| Mar 4, 2026 | Sujal M Patel (CEO) | Bought | $65.2K |
| Mar 2, 2026 | Parag Mallick (Officer) | Bought (not open market) | — |
| Mar 2, 2026 | Sujal M Patel (CEO) | Bought (not open market) | — |
| Mar 2, 2026 | Matthew B. Murphy (General Counsel) | Bought (not open market) | — |
| Mar 2, 2026 | Anna Mowry (CFO) | Bought (not open market) | — |
| Mar 2, 2026 | Gwen E Weld (C-suite exec) | Bought (not open market) | — |
| Mar 2, 2026 | Subramanian Sankar (VP) | Bought (not open market) | — |
| Mar 2, 2026 | Kentaro Suzuki (C-suite exec) | Bought (not open market) | — |
| Nov 6, 2025 | Kentaro Suzuki (C-suite exec) | Bought | $6K |
Who's trading NAUT
- Matthew S McIlwain, Director: other filings, last Jun 18, 2026
- Matthew L. Posard, Director: other filings, last Jun 18, 2026
- Karen Akinsanya, Director: other filings, last Jun 18, 2026
- Melissa B Epperly, Director: other filings, last Jun 18, 2026
- Farzad Nazem, Director: other filings, last Jun 18, 2026
- AH Equity Partners Bio II L.L.C., Insider: sold $11.8M (2 sales), last Jun 2, 2026
- Sujal M Patel, CEO: bought $65.2K (1 buy), last Mar 4, 2026
- Anna Mowry, CFO: other filings, last Mar 2, 2026
- Matthew B. Murphy, General Counsel: other filings, last Mar 2, 2026
- Parag Mallick, Officer: other filings, last Mar 2, 2026
- Subramanian Sankar, VP: other filings, last Mar 2, 2026
- Kentaro Suzuki, C-suite exec: bought $6K (1 buy), last Mar 2, 2026
- Gwen E Weld, C-suite exec: other filings, last Mar 2, 2026
Get free alerts when an insider at Nautilus Biotechnology, Inc files a new trade →